Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

L’Oreal Falls Short On Safety, Efficacy, Adverse Event Data

This article was originally published in The Tan Sheet

Executive Summary

FDA says it needs additional data from L’Oreal on safety, efficacy and adverse events to determine GRASE for drometrizole trisiloxane.

Advertisement

Related Content

Adverse-Event Data Requirement Among Sunscreen TEA Bugs – FDA
Senators Optimistic As Sunscreen Bill Heads For HELP Committee Markup
Flaws In TEA Process Delay Reviews, Monograph Changes – FDA
Flaws In TEA Process Delay Reviews, Monograph Changes – FDA
A Common FDA Refrain: BASF, L’Oreal Sunscreen TEAs Need More Information
A Common FDA Refrain: BASF, L’Oreal Sunscreen TEAs Need More Information
CHPA “Neutral” On Requiring Deadlines For TEA Reviews
CHPA “Neutral” On Requiring Deadlines For TEA Reviews
FDA Deems UVA Filter Ecamsule Eligible For Monograph Inclusion, Seeks Data

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS107143

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel